Core Capabilities of ModAstera
Medical AI Engineering Agent (MAEA): Your Clinical AI Co-Pilot
MAEA acts as an autonomous engineering partner—interpreting clinical requirements, selecting appropriate validation strategies, tuning hyperparameters with domain-aware constraints, and orchestrating end-to-end model delivery. It excels at segmentation (e.g., tumor boundary detection), classification (e.g., pathology triage), and multimodal fusion tasks—while maintaining full traceability and reproducibility.
AI-Augmented Annotation Studio
Go beyond basic labeling: ModAstera’s annotation engine uses foundation models fine-tuned on medical ontologies to pre-annotate CT scans, histopathology slides, and longitudinal EHR sequences—with clinician-in-the-loop review workflows, DICOM-native support, and customizable annotation schemas aligned with ICD, SNOMED, and LOINC standards.
Regulatory-Ready Model Library
Jumpstart development with clinically validated, pre-integrated models—including FDA-cleared reference implementations for diabetic retinopathy grading, lung nodule characterization, and sepsis risk prediction. Each model ships with built-in explainability reports, bias audits, and HIPAA-compliant inference APIs—ready for integration into PACS, EHRs, or edge devices.
Unified Compliance-First Platform
The ModAstera platform embeds governance at every layer: automatic PHI redaction, audit trail generation, SOC 2-aligned infrastructure, real-time compliance dashboards for HIPAA, APPI, and GDPR, and continuous monitoring of model drift and data quality—ensuring your AI remains trustworthy, transparent, and audit-ready from day one.
Real-World Applications
Accelerating clinical AI R&D without sacrificing regulatory integrity
Scaling AI development across distributed research teams and hospital systems
Building FDA-submission-ready models with automated MDR/ISO 13485 documentation
Transforming raw imaging, genomic, or wearable sensor data into deployable clinical decision tools
Enabling rapid prototyping and iterative validation of AI hypotheses in real-world clinical settings
Reducing annotation burden by >70% while improving inter-rater agreement in multi-site studies
Maintaining continuous compliance across model lifecycle—from development through post-market surveillance
Empowering clinicians and domain experts to co-develop AI—not just consume it
Frequently Asked Questions
-
What is ModAstera?
-
How does ModAstera compress R&D timelines and reduce total cost of AI ownership?
-
What makes ModAstera’s platform different from generic MLOps tools?
-
How does ModAstera ensure adherence to healthcare regulations like HIPAA and APPI?
-
Who benefits most from using ModAstera?
-
Support & Contact Information
For technical support, customer success, or refund inquiries: contact our team at [email protected]. Visit the official contact page for regional support hours, SLA details, and escalation paths.
-
About ModAstera Inc.
Company Name: ModAstera Inc. Registered Address: 〒 103-0025 FinGATE KAYABA 3F, 1−8−1 Nihonbashikayabacho, Chuo City, Tokyo, Japan.
Learn about our mission, clinical advisory board, and regulatory partnerships: About ModAstera.
-
Connect With Us
Follow our latest clinical AI insights, regulatory updates, and product releases: ModAstera on LinkedIn